198 related articles for article (PubMed ID: 12228753)
1. Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate.
Foster R; Bihrle R
Cancer Control; 2002; 9(4):277-83. PubMed ID: 12228753
[TBL] [Abstract][Full Text] [Related]
2. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer.
Skolarus TA; Bhayani SB; Chiang HC; Brandes SB; Kibel AS; Landman J; Figenshau RS
J Endourol; 2008 Jul; 22(7):1485-9. PubMed ID: 18613781
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
[TBL] [Abstract][Full Text] [Related]
5. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
6. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP
Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730
[TBL] [Abstract][Full Text] [Related]
7. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
8. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
[TBL] [Abstract][Full Text] [Related]
9. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
10. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
Rabbani F; Farivar-Mohseni H; Leon A; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2003 Dec; 62(6):1092-6. PubMed ID: 14665362
[TBL] [Abstract][Full Text] [Related]
14. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal lymph node dissection: an update in testicular malignancies.
Yadav K
Clin Transl Oncol; 2017 Jul; 19(7):793-798. PubMed ID: 28150168
[TBL] [Abstract][Full Text] [Related]
16. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
17. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
19. Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.
Heidenreich A; Ohlmann C; Hegele A; Beyer J
Eur Urol; 2005 Jan; 47(1):64-71. PubMed ID: 15582251
[TBL] [Abstract][Full Text] [Related]
20. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
